Award
Delivery Order #SPE2DP26F3487
Delivery Order for Ketorolac Tromethamine by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$683.88
Ceiling
$683.88
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 26, 2026
Identifier
SPE2DP26F3487
NAICS
424210
This award is a delivery order contract granted under the umbrella of a larger indefinite delivery vehicle (IDV) pharmaceutical supply agreement. The recipient, DMS Pharmaceutical Group Inc., a specialized distributor in pharmaceutical products, is tasked with providing specific drug inventories. The order focuses on procuring Ketorolac Tromethamine, a critical medication often used for pain management. The significance of this contract lies in its role in maintaining timely availability of vital drugs to support federal health initiatives. The scope of work involves the delivery of this medication within a short, defined period, ensuring the agency's immediate supply needs are met efficiently. This transaction is part of a broader, competitive procurement strategy established by a prior definitive contract and is not a sole-source award. The timeline for this delivery order is concise, covering a fortnight in early 2026, highlighting an agile and responsive supply operation within the larger multi-year contract framework.
Description
8511972803!KETOROLAC TROMETHAM